Patents by Inventor Sandra Ann CARSON
Sandra Ann CARSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10959757Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: GrantFiled: March 1, 2018Date of Patent: March 30, 2021Assignee: Previvo Genetics, Inc.Inventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Patent number: 10952773Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: GrantFiled: August 3, 2017Date of Patent: March 23, 2021Assignee: Previvo Genetics, Inc.Inventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Patent number: 10945762Abstract: A process for recovering one or more blastocysts from a uterus of a human includes a step of placing a device transvaginally into a cervical canal of the patient; a step of delivering fluid through the device to the uterus and applying a vacuum to a uterus of the patient to aspirate fluid and entrained one or more blastocysts from the uterus; and a step of performing a biopsy procedure on the one or more recovered blastocysts to remove one or more of trophectoderm cells or inner cell mass from the recovered blastocysts. The process may further include a step of storing one or more of the biopsied trophectoderm cells or inner cell mass following the biopsy procedure and a step of performing at least one molecular diagnostic assay test on the one or more of the biopsied trophectoderm cells or inner cell mass.Type: GrantFiled: October 31, 2018Date of Patent: March 16, 2021Assignee: Previvo Genetics, Inc.Inventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Publication number: 20190133641Abstract: A process for recovering one or more blastocysts from a uterus of a human is disclose which comprises placing a device transvaginally into a cervical canal of the patient; delivering fluid through the device to the uterus and applying a vacuum to the uterus to aspirate fluid and entrained one or more blastocysts from the uterus; and causing a disruption of to the uterus and/or to one or more embryos remaining in the uterus following removal of one or more blastocysts from the uterus to reduce the chance that any such retained embryos remaining in the uterus will form a viable pregnancy, wherein the causing a disruption comprises one or more of the following: inducing a mechanical disruption of the uterus, delivering a hormonal agent to the uterus, delivering a chemical agent to the uterus, inducing a thermal disruption of the uterus, or using ultrasound or radiofrequency energy to induce said disruption.Type: ApplicationFiled: October 31, 2018Publication date: May 9, 2019Inventors: Sandra Ann CARSON, John E. BUSTER, Moses CESARIO, Steven Paul WOODARD
-
Publication number: 20190083134Abstract: A process for recovering one or more blastocysts from a uterus of a human is disclose which comprises placing a device transvaginally into a cervical canal of the patient; delivering fluid through the device to the uterus and applying a vacuum to the uterus to aspirate fluid and entrained one or more blastocysts from the uterus; and causing a disruption of to the uterus and/or to one or more embryos remaining in the uterus following removal of one or more blastocysts from the uterus to reduce the chance that any such retained embryos remaining in the uterus will form a viable pregnancy, wherein the causing a disruption comprises one or more of the following: inducing a mechanical disruption of the uterus, delivering a hormonal agent to the uterus, delivering a chemical agent to the uterus, inducing a thermal disruption of the uterus, or using ultrasound or radiofrequency energy to induce said disruption.Type: ApplicationFiled: September 13, 2018Publication date: March 21, 2019Inventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Patent number: 10226280Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: GrantFiled: July 30, 2015Date of Patent: March 12, 2019Assignee: Previvo Genetics, LLCInventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Patent number: 10213230Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: GrantFiled: July 30, 2015Date of Patent: February 26, 2019Assignee: Previvo Genetics, LLCInventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Publication number: 20180289395Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: ApplicationFiled: March 1, 2018Publication date: October 11, 2018Applicant: Previvo Genetics, Inc.Inventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Patent number: 9943334Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: GrantFiled: July 30, 2015Date of Patent: April 17, 2018Assignee: Previvo Genetics, Inc.Inventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Publication number: 20180015138Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: ApplicationFiled: August 3, 2017Publication date: January 18, 2018Applicant: Previvo Genetics, Inc.Inventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Publication number: 20170224379Abstract: A process for recovering one or more blastocysts from a uterus of a human is disclose which comprises placing a device transvaginally into a cervical canal of the patient; delivering fluid through the device to the uterus and applying a vacuum to the uterus to aspirate fluid and entrained one or more blastocysts from the uterus; and causing a disruption of to the uterus and/or to one or more embryos remaining in the uterus following removal of one or more blastocysts from the uterus to reduce the chance that any such retained embryos remaining in the uterus will form a viable pregnancy, wherein the causing a disruption comprises one or more of the following: inducing a mechanical disruption of the uterus, delivering a hormonal agent to the uterus, delivering a chemical agent to the uterus, inducing a thermal disruption of the uterus, or using ultrasound or radiofrequency energy to induce said disruption.Type: ApplicationFiled: April 27, 2017Publication date: August 10, 2017Applicant: Previvo Genetics, Inc.Inventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Patent number: 9561257Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: GrantFiled: July 30, 2015Date of Patent: February 7, 2017Assignee: Previvo Genetics, Inc.Inventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Publication number: 20160151090Abstract: A process for recovering one or more blastocysts from a uterus of a human is disclose which comprises placing a device transvaginally into a cervical canal of the patient; delivering fluid through the device to the uterus and applying a vacuum to the uterus to aspirate fluid and entrained one or more blastocysts from the uterus; and causing a disruption of to the uterus and/or to one or more embryos remaining in the uterus following removal of one or more blastocysts from the uterus to reduce the chance that any such retained embryos remaining in the uterus will form a viable pregnancy, wherein the causing a disruption comprises one or more of the following: inducing a mechanical disruption of the uterus, delivering a hormonal agent to the uterus, delivering a chemical agent to the uterus, inducing a thermal disruption of the uterus, or using ultrasound or radiofrequency energy to induce said disruption.Type: ApplicationFiled: November 17, 2015Publication date: June 2, 2016Applicant: Previvo Genetics, LLCInventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Patent number: 9282995Abstract: Among other things, uterine lavage is performed to withdraw at least 50% of in vivo fertilized preimplantation embryos produced after superovulation of a woman and artificial insemination using sperm of her sexual partner. After genetic diagnosis or sex determination or gene therapy, or any combination of any two or more of them, of the recovered embryos and selection of at least one of the embryos to be implanted, the selected embryos are returned to the woman for implantation in her uterus.Type: GrantFiled: December 22, 2011Date of Patent: March 15, 2016Assignee: Previvo Genetics, LLCInventors: Sandra Ann Carson, John E. Buster
-
Patent number: 9247960Abstract: Among other things, uterine lavage is performed to withdraw at least 50% of in vivo fertilized preimplantation embryos produced after superovulation of a woman and artificial insemination using sperm of her sexual partner. After genetic diagnosis or sex determination or gene therapy, or any combination of any two or more of them, of the recovered embryos and selection of at least one of the embryos to be implanted, the selected embryos are returned to the woman for implantation in her uterus.Type: GrantFiled: April 10, 2014Date of Patent: February 2, 2016Assignee: Previvo Genetics, LLCInventors: Sandra Ann Carson, John E. Buster
-
Patent number: 9247959Abstract: Among other things, uterine lavage is performed to withdraw at least 50% of in vivo fertilized preimplantation embryos produced after superovulation of a woman and artificial insemination using sperm of her sexual partner. After genetic diagnosis or sex determination or gene therapy, or any combination of any two or more of them, of the recovered embryos and selection of at least one of the embryos to be implanted, the selected embryos are returned to the woman for implantation in her uterus.Type: GrantFiled: December 22, 2011Date of Patent: February 2, 2016Assignee: Previvo Genetics, LLCInventors: Sandra Ann Carson, John E. Buster
-
Publication number: 20150335354Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: ApplicationFiled: July 30, 2015Publication date: November 26, 2015Applicant: Previvo Genetics, LLCInventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Publication number: 20150335700Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: ApplicationFiled: July 30, 2015Publication date: November 26, 2015Applicant: Previvo Genetics, LLCInventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Publication number: 20150335701Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: ApplicationFiled: July 30, 2015Publication date: November 26, 2015Applicant: Previvo Genetics, LLCInventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard
-
Publication number: 20150272622Abstract: A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.Type: ApplicationFiled: March 9, 2015Publication date: October 1, 2015Applicant: PREVIVO GENETICS, LLCInventors: Sandra Ann Carson, John E. Buster, Moses Cesario, Steven Paul Woodard